Tag Archives: Pfizer

Pharma’s Foreign Corrupt Practices Accompany Its Domestic Violations

Worst Pills Best Pills Newsletter article October, 2013 Between 1991 and mid-2012, U.S. drug companies paid a total of more than $30 billion for domestic criminal or civil violations, including withholding safety information from the Food and Drug Administration (FDA), … Continue reading

Posted in Pharmaceutical Promotion | Tagged , , , , , , , , | Leave a comment

Two complaints upheld

The determinations by the Therapeutic Goods Advertising Complaint Resolution Panel (TGACRP) and Medicines Australia Code of Conduct Committee respectively can be viewed here: Undoit determination Pfizer Lipitor determination

Posted in Complementary medicine, Pharmaceutical Promotion | Tagged , , , | Leave a comment